Enrolling Clinical Research Studies
Psychiatry
PTSD
PTSD
A Phase IIb/III, multicenter, randomised, double-blind, controlled study, with an open-label extension, to investigate the efficacy, safety, and tolerability of COMP360 in participants with post-traumatic stress disorder
Upcoming Studies
Future Studies
Future Clinical Trials
If you would like to submit your information to be contacted for future study opportunities in Vancouver, click to apply here.
Treatment Resistant Depression
Treatment Resistant Depression
ReConnection-2: A phase 3, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of two doses of intranasal BPL-003 in participants with treatment resistant depression with an open-label extension